Skip to content
Tregalizumab
Tregalizumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target T-cell surface glycoprotein CD4.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rheumatoid arthritisD001172EFO_0000685M06.922
AsthmaD001249EFO_0000270J4511
HypersensitivityD006967EFO_0003785T78.4011
PsoriasisD011565EFO_0000676L4011
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTREGALIZUMAB
INNtregalizumab
Description
Tregalizumab (humanized mab)
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID1207446-68-1
RxCUI
ChEMBL IDCHEMBL1743083
ChEBI ID
PubChem CID
DrugBankDB13073
UNII ID43D26MK176 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
CD4
CD4
Organism
Homo sapiens
Gene name
CD4
Gene synonyms
NCBI Gene ID
Protein name
T-cell surface glycoprotein CD4
Protein synonyms
CD4, CD4 antigen (p55), CD4 receptor, T-cell surface antigen T4/Leu-3
Uniprot ID
Mouse ortholog
Cd4 (12504)
T-cell surface glycoprotein CD4 (P06332)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 41 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details